Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsin gpost BMT. - Slavin,S.; Naparstek,E.; Nagler,A.; Kapelushnik,Y.; Ackerstein,A.; Or,R. (Blood, 1996)